These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
243 related articles for article (PubMed ID: 11847592)
21. Multistability in a model for CTL response to HTLV-I infection and its implications to HAM/TSP development and prevention. Gómez-Acevedo H; Li MY; Jacobson S Bull Math Biol; 2010 Apr; 72(3):681-96. PubMed ID: 20041353 [TBL] [Abstract][Full Text] [Related]
22. Virological aspects of tropical spastic paraparesis/HTLV-I associated myelopathy and HTLV-I infection. Gessain A J Neurovirol; 1996 Oct; 2(5):299-306. PubMed ID: 8912206 [TBL] [Abstract][Full Text] [Related]
23. Minocycline modulates antigen-specific CTL activity through inactivation of mononuclear phagocytes in patients with HTLV-I associated neurologic disease. Enose-Akahata Y; Matsuura E; Tanaka Y; Oh U; Jacobson S Retrovirology; 2012 Feb; 9():16. PubMed ID: 22335964 [TBL] [Abstract][Full Text] [Related]
24. Diversity of intrathecal antibody synthesis against HTLV-I and its relation to HTLV-I associated myelopathy. Kitze B; Usuku K; Izumo S; Nakamura M; Shiraki H; Ijichi S; Yashiki S; Fujiyoshi T; Sonoda S; Osame M J Neurol; 1996 May; 243(5):393-400. PubMed ID: 8741079 [TBL] [Abstract][Full Text] [Related]
25. HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP): the role of HTLV-I-infected Th1 cells in the pathogenesis, and therapeutic strategy. Nakamura T Folia Neuropathol; 2009; 47(2):182-94. PubMed ID: 19618340 [TBL] [Abstract][Full Text] [Related]
26. Cellular immune responses to HTLV-I: immunopathogenic role in HTLV-I-associated neurologic disease. Jacobson S J Acquir Immune Defic Syndr Hum Retrovirol; 1996; 13 Suppl 1():S100-6. PubMed ID: 8797711 [TBL] [Abstract][Full Text] [Related]
27. Increased HTLV type 1 tax specific CD8+ cells in HTLV type 1-asociated myelopathy/tropical spastic paraparesis: correlation with HTLV type 1 proviral load. Kubota R; Nagai M; Kawanishi T; Osame M; Jacobson S AIDS Res Hum Retroviruses; 2000 Nov; 16(16):1705-9. PubMed ID: 11080814 [TBL] [Abstract][Full Text] [Related]
28. Characterization of MHC class I restricted cytotoxic T cell responses to tax in HTLV-1 infected patients with neurologic disease. Koenig S; Woods RM; Brewah YA; Newell AJ; Jones GM; Boone E; Adelsberger JW; Baseler MW; Robinson SM; Jacobson S J Immunol; 1993 Oct; 151(7):3874-83. PubMed ID: 7690819 [TBL] [Abstract][Full Text] [Related]
29. Limited T cell receptor usage by HTLV-I tax-specific, HLA class I restricted cytotoxic T lymphocytes from patients with HTLV-I associated neurological disease. Elovaara I; Utz U; Smith S; Jacobson S J Neuroimmunol; 1995 Dec; 63(1):47-53. PubMed ID: 8557824 [TBL] [Abstract][Full Text] [Related]
30. Increased HTLV-I proviral load and preferential expansion of HTLV-I Tax-specific CD8+ T cells in cerebrospinal fluid from patients with HAM/TSP. Nagai M; Yamano Y; Brennan MB; Mora CA; Jacobson S Ann Neurol; 2001 Dec; 50(6):807-12. PubMed ID: 11761481 [TBL] [Abstract][Full Text] [Related]
31. Immunopathogenesis of HTLV-I-associated myelopathy/tropical spastic paraparesis. Nakamura T Ann Med; 2000 Dec; 32(9):600-7. PubMed ID: 11209967 [TBL] [Abstract][Full Text] [Related]
32. High IFN-γ/IL-10 expression ratio and increased frequency of persistent human T-cell lymphotropic virus type 1-infected clones are associated with human T-cell lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis development. Espíndola OM; Oliveira LC; Ferreira PM; Leite AC; Lima MA; Andrada-Serpa MJ Intervirology; 2015; 58(2):106-14. PubMed ID: 25833232 [TBL] [Abstract][Full Text] [Related]
33. Presence of HTLV-I Tax protein in cerebrospinal fluid from HAM/TSP patients. Cartier L; Ramirez E Arch Virol; 2005 Apr; 150(4):743-53. PubMed ID: 15592888 [TBL] [Abstract][Full Text] [Related]
34. Human T cell leukemia virus Type I (HTLV-I) infection induces greater expansions of CD8 T lymphocytes in persons with HTLV-I-associated myelopathy/tropical spastic paraparesis than in asymptomatic carriers. Ureta-Vidal A; Pique C; Garcia Z; Dehée A; Tortevoye P; Désiré N; Gessain A; Chancerel B; Gout O; Lemonnier FA; Cochet M J Infect Dis; 2001 Mar; 183(6):857-64. PubMed ID: 11237801 [TBL] [Abstract][Full Text] [Related]
35. Detection of human T-lymphotropic virus type I p40tax protein in cerebrospinal fluid cells from patients with human T-lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis. Moritoyo T; Izumo S; Moritoyo H; Tanaka Y; Kiyomatsu Y; Nagai M; Usuku K; Sorimachi M; Osame M J Neurovirol; 1999 Jun; 5(3):241-8. PubMed ID: 10414514 [TBL] [Abstract][Full Text] [Related]
36. Predominant recognition of human T cell leukemia virus type I (HTLV-I) pX gene products by human CD8+ cytotoxic T cells directed against HTLV-I-infected cells. Kannagi M; Harada S; Maruyama I; Inoko H; Igarashi H; Kuwashima G; Sato S; Morita M; Kidokoro M; Sugimoto M Int Immunol; 1991 Aug; 3(8):761-7. PubMed ID: 1911545 [TBL] [Abstract][Full Text] [Related]
37. Clonal expansion of CD8+ cytotoxic T lymphocytes against human T cell lymphotropic virus type I (HTLV-I) genome products in HTLV-I-associated myelopathy/tropical spastic paraparesis patients. Furukawa K; Mori M; Ohta N; Ikeda H; Shida H; Furukawa K; Shiku H J Clin Invest; 1994 Nov; 94(5):1830-9. PubMed ID: 7962528 [TBL] [Abstract][Full Text] [Related]
38. Increased expression of human T lymphocyte virus type I (HTLV-I) Tax11-19 peptide-human histocompatibility leukocyte antigen A*201 complexes on CD4+ CD25+ T Cells detected by peptide-specific, major histocompatibility complex-restricted antibodies in patients with HTLV-I-associated neurologic disease. Yamano Y; Cohen CJ; Takenouchi N; Yao K; Tomaru U; Li HC; Reiter Y; Jacobson S J Exp Med; 2004 May; 199(10):1367-77. PubMed ID: 15136590 [TBL] [Abstract][Full Text] [Related]
39. Anti-HTLV antibody profiling reveals an antibody signature for HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP). Burbelo PD; Meoli E; Leahy HP; Graham J; Yao K; Oh U; Janik JE; Mahieux R; Kashanchi F; Iadarola MJ; Jacobson S Retrovirology; 2008 Oct; 5():96. PubMed ID: 18937847 [TBL] [Abstract][Full Text] [Related]
40. Expression of the target antigen for cytotoxic T lymphocytes on adult T-cell-leukemia cells. Kannagi M; Matsushita S; Harada S Int J Cancer; 1993 Jun; 54(4):582-8. PubMed ID: 8514449 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]